Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4800540
Max Phase: Preclinical
Molecular Formula: C22H18N2O4
Molecular Weight: 374.40
Molecule Type: Unknown
Associated Items:
ID: ALA4800540
Max Phase: Preclinical
Molecular Formula: C22H18N2O4
Molecular Weight: 374.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(N2C(=O)c3ccccc3C2=O)c(C)cc1NC(=O)c1occc1C
Standard InChI: InChI=1S/C22H18N2O4/c1-12-8-9-28-19(12)20(25)23-17-10-14(3)18(11-13(17)2)24-21(26)15-6-4-5-7-16(15)22(24)27/h4-11H,1-3H3,(H,23,25)
Standard InChI Key: YKWJRPULGJFKTR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 374.40 | Molecular Weight (Monoisotopic): 374.1267 | AlogP: 4.26 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.62 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.27 | CX LogD: 4.27 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.69 | Np Likeness Score: -1.32 |
1. Davis DC,Bungard JD,Chang S,Rodriguez AL,Blobaum AL,Boutaud O,Melancon BJ,Niswender CM,Jeffrey Conn P,Lindsley CW. (2021) Lead optimization of the VU0486321 series of mGlu PAMs. Part 4: SAR reveals positive cooperativity across multiple mGlu receptor subtypes leading to subtype unselective PAMs., 32 [PMID:33253881] [10.1016/j.bmcl.2020.127724] |
Source(1):